Cargando…
COVID-19 infection in hypereosinophilic syndrome: A survey-based analysis
Autores principales: | Espinoza, David F., Wetzler, Lauren, Holland, Nicole, Moodley, Neshen, Ware, Jeananne, Klion, Amy, Khoury, Paneez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891145/ https://www.ncbi.nlm.nih.gov/pubmed/35248766 http://dx.doi.org/10.1016/j.jaip.2022.02.019 |
Ejemplares similares
-
Clinical and Biological Markers in Hypereosinophilic Syndromes
por: Khoury, Paneez, et al.
Publicado: (2017) -
PB2229: A PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH HYPEREOSINOPHILIC SYNDROME
por: Ogbogu, Princess, et al.
Publicado: (2023) -
Genomics of PDGFR-rearranged hypereosinophilic syndrome
por: Rheinbay, Esther, et al.
Publicado: (2023) -
Hypereosinophilic syndromes
por: Roufosse, Florence E, et al.
Publicado: (2007) -
Long-term Follow-up of Severe Eosinophilic Hepatitis: A Rare Presentation of Hypereosinophilic Syndrome
por: Awadie, Halim, et al.
Publicado: (2019)